Literature DB >> 8098410

Improvement of cholestatic pruritus by ondansetron.

H Schwörer, G Ramadori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8098410     DOI： 10.1016/0140-6736(93)91178-o

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  Pruritus.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-12

Review 2.  Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy.

Authors:  Thomas Pusl; Ulrich Beuers
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

Review 3.  Intrahepatic cholestasis of pregnancy.

Authors:  Victoria Geenes; Catherine Williamson
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

4.  Why do cholestatic patients itch?

Authors:  E A Jones; N V Bergasa
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

5.  Ondansetron for pruritus in child with chronic cholestasis.

Authors:  P Trioche; D Samuel; M Odièvre; P Labrune
Journal:  Eur J Pediatr       Date:  1996-11       Impact factor: 3.183

6.  Ondansetron to treat pruritus due to cholestatic jaundice.

Authors:  Sarah Dillon; Joseph D Tobias
Journal:  J Pediatr Pharmacol Ther       Date:  2013-07

Review 7.  Pruritus: management algorithms and experimental therapies.

Authors:  Martin Steinhoff; Ferda Cevikbas; Akihiko Ikoma; Timothy G Berger
Journal:  Semin Cutan Med Surg       Date:  2011-06

Review 8.  5-HT3 receptors.

Authors:  A J Thompson; S C R Lummis
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 9.  Clinical features and management of primary biliary cirrhosis.

Authors:  Andrea Crosignani; Pier-Maria Battezzati; Pietro Invernizzi; Carlo Selmi; Elena Prina; Mauro Podda
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

Review 10.  Pathogenesis and treatment of pruritus in cholestasis.

Authors:  Andreas E Kremer; Ulrich Beuers; Ronald P J Oude-Elferink; Thomas Pusl
Journal:  Drugs       Date:  2008       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.